Evidence map›Paper›PMID 38789013›Full record

ArticleThe Journal of infection2024

Epidemiological surveillance of acute respiratory infections based on targeted metagenomic next generation sequencing during the flu season after COVID-19 pandemic in Beijing.

Bing Han, Xu-Ming Li, Ran Li, Wu Ning, Yuan-Yuan Zhang, Yan-Fen Tang, Ye Zhang, Long Hu, Jian-Dong Li, Gang Liu and 5 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in The Journal of infection, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Bing HanDiagnosis and Treatment Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Xu-Ming LiDepartment of Scientific Affairs, Hugobiotech Co., Ltd., Bejing 100176, China.
Ran LiDepartment of Infectious and Clinical Microbiology, Beijing Institute of Respiratory Medicine and Beijing Chao-yang Hospital, Capital Medical University, Beijing 100043, China.
Wu NingDepartment of Infectious Diseases, Peking University Shougang Hospital, Beijing 100144, China.
Yuan-Yuan ZhangNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing100015, China; Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China; Beijing Institute of Infectious Diseases, Beijing 100015, China; National Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Yan-Fen TangDiagnosis and Treatment Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China; Department of Respiratory, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
Ye ZhangDepartment of Scientific Affairs, Hugobiotech Co., Ltd., Bejing 100176, China.
Long HuDepartment of Scientific Affairs, Hugobiotech Co., Ltd., Bejing 100176, China.
Jian-Dong LiNHC Key Laboratory of Medical Virology and Viral Diseases, NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Gang LiuDepartment of Infectious Diseases, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Beijing 100045, China.
Dan ZhangDepartment of Infectious Diseases, Peking University Shougang Hospital, Beijing 100144, China.
Li GuDepartment of Infectious and Clinical Microbiology, Beijing Institute of Respiratory Medicine and Beijing Chao-yang Hospital, Capital Medical University, Beijing 100043, China.
Han XiaDepartment of Scientific Affairs, Hugobiotech Co., Ltd., Bejing 100176, China.
Xi WangNational Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing100015, China; Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China; Beijing Institute of Infectious Diseases, Beijing 100015, China; National Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China. Electronic address: xiwang@ccmu.edu.cn.
Rong-Meng JiangDiagnosis and Treatment Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China. Electronic address: 13911900791@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19High-Throughput Nucleotide SequencingMetagenomicsAdolescentAdultAgedBeijingChildChild, PreschoolEpidemiological MonitoringFemaleHumansInfluenza, HumanMaleMiddle AgedRespiratory Tract Infections

Identifiers

PMID38789013

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.